In order the improvement medicine of C type hepatitis curative effect and

摘要

The present invention is an effective component of hepatitis C therapy, IFN -. Alpha. And IFN -. Gamma., which can further enhance hepatitis C therapy effect by IFN -. Alpha., and C type therapeutic composition including IFC -. Alpha. And IFN -. Gamma. Pharmaceuticals including pharmaceutically acceptable carriers, and more It is a treatment method of hepatitis C which either administers IFN - u03b1 and IFN - u03b3 simultaneously or injects IFN - u03b3 before administration of IFN -. Alpha.. The present invention is highly effective for the treatment of IFN -. Alpha. Refractory chronic hepatitis C, which is difficult to treat.